Financials Krsnaa Diagnostics Limited

Equities

KRSNAA

INE08LI01020

Healthcare Facilities & Services

Market Closed - NSE India S.E. Other stock markets 07:43:52 2024-05-30 EDT			5-day change	1st Jan Change
580 ^INR	+1.37%		-2.26%	-17.85%

05-21	Transcript : Krsnaa Diagnostics Limited, Q4 2024 Earnings Call, May 21, 2024
05-20	Krsnaa Diagnostics Names CEO	MT

Valuation

Fiscal Period: March	2022	2023	2024	2025	2026
Capitalization ¹	15,344	14,449	18,726	-	-
Enterprise Value (EV) ¹	15,344	14,449	19,845	18,726	18,726
P/E ratio	21.4 x	23.3 x	34.3 x	20.3 x	12.6 x
Yield	-	-	0.35%	0.52%	0.87%
Capitalization / Revenue	3.37 x	2.97 x	3.2 x	2.31 x	1.68 x
EV / Revenue	3.37 x	2.97 x	3.2 x	2.31 x	1.68 x
EV / EBITDA	11.7 x	11.8 x	13.8 x	8.99 x	6.47 x
EV / FCF	-404 x	-22.2 x	-38.5 x	29.9 x	264 x
FCF Yield	-0.25%	-4.5%	-2.6%	3.35%	0.38%
Price to Book	2.13 x	1.96 x	2.28 x	2.06 x	1.79 x
Nbr of stocks (in thousands)	31,398	31,398	32,290	-	-
Reference price ²	488.7	460.2	572.1	572.1	572.1
Announcement Date	5/28/22	5/27/23	5/18/24	-	-

¹INR in Million²INR

Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March	2021	2022	2023	2024	2025	2026
Net sales ¹	-	4,554	4,871	6,196	8,090	11,120
EBITDA ¹	-	1,315	1,223	1,442	2,084	2,896
EBIT ¹	-	900.9	685.2	697	1,212	1,866
Operating Margin	-	19.78%	14.07%	11.25%	14.98%	16.79%
Earnings before Tax (EBT) ¹	-	865.1	802	700.1	1,153	1,874
Net income ¹	1,849	683.9	621.1	568.4	898.5	1,446
Net margin	-	15.02%	12.75%	9.17%	11.11%	13%
EPS ²	-	22.88	19.78	17.90	28.15	45.40
Free Cash Flow ¹	-	-37.95	-650.6	-486	627	71
FCF margin	-	-0.83%	-13.36%	-7.96%	7.75%	0.64%
FCF Conversion (EBITDA)	-	-	-	-	30.09%	2.45%
FCF Conversion (Net income)	-	-	-	-	69.78%	4.91%
Dividend per Share ²	-	-	-	2.000	3.000	5.000
Announcement Date	8/3/21	5/28/22	5/27/23	5/18/24	-	-

¹INR in Million²INR

Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4
Net sales ¹	-	1,226	1,332	1,396	1,608	1,550	1,650
EBITDA ¹	-	294.1	344.8	313.6	403	348	403
EBIT	-	-	-	-	-	186	226
Operating Margin	-	-	-	-	-	12%	13.7%
Earnings before Tax (EBT)	-	-	-	-	-	-	-
Net income ¹	153.4	136.4	189.2	146.4	203.5	146	153.5
Net margin	-	11.12%	14.2%	10.49%	12.66%	9.42%	9.31%
EPS	-	-	-	-	7.400	5.350	5.000
Dividend per Share	-	-	-	-	-	-	-
Announcement Date	11/9/22	2/13/23	5/27/23	8/12/23	-	-	-

¹INR in Million

Estimates

Balance Sheet Analysis

Fiscal Period: March	2021	2022	2023	2024	2025	2026
Net Debt	-	-	-	-	-	-
Net Cash position	-	-	-	-	-	-
Leverage (Debt/EBITDA)	-	-	-	-	-	-
Free Cash Flow ¹	-	-38	-651	-486	627	71
ROE (net income / shareholders' equity)	-	14.9%	8.73%	7.25%	10.7%	15.2%
ROA (Net income/ Total Assets)	-	-	-	-	-	-
Assets ¹	-	-	-	-	-	-
Book Value Per Share ²	-	229.0	235.0	251.0	277.0	320.0
Cash Flow per Share	-	-	-	-	-	-
Capex ¹	-	1,322	1,414	1,675	1,451	2,000
Capex / Sales	-	29.03%	29.02%	27.45%	17.94%	17.99%
Announcement Date	8/3/21	5/28/22	5/27/23	5/18/24	-	-

¹INR in Million²INR

Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Krsnaa Diagnostics Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

572.1 INR

Average target price

970 INR

Spread / Average Target

+69.55%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

	1st Jan change	Capi.
KRSNAA DIAGNOSTICS LIMITED	-17.85%	222M
SONIC HEALTHCARE LIMITED	-25.19%	7.67B
RADNET, INC.	+72.25%	4.38B
SYNLAB AG	-7.36%	2.52B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-44.46%	2.23B
NEOGENOMICS, INC.	-13.26%	1.77B
FLEURY S.A.	-21.62%	1.52B
METROPOLIS HEALTHCARE LIMITED	+17.46%	1.21B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-43.89%	1.14B
VIJAYA DIAGNOSTIC CENTRE LIMITED	+19.93%	997M

Medical & Diagnostic Laboratories